X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (70) 70
humans (61) 61
hematology (50) 50
oncology (50) 50
female (41) 41
male (39) 39
lymphomas (37) 37
middle aged (35) 35
rituximab (34) 34
chemotherapy (33) 33
aged (32) 32
adult (30) 30
article (28) 28
lymphoma (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
survival (22) 22
cancer (19) 19
non-hodgkin lymphoma (19) 19
treatment outcome (19) 19
young adult (19) 19
b-cell lymphoma (18) 18
non-hodgkins-lymphoma (18) 18
follicular lymphoma (17) 17
radiotherapy (17) 17
aged, 80 and over (16) 16
care and treatment (16) 16
neoplasm staging (16) 16
prognosis (15) 15
united-states (15) 15
non-hodgkin-lymphoma (14) 14
retrospective studies (13) 13
abridged index medicus (12) 12
disease-free survival (12) 12
hemic and lymphatic diseases (11) 11
lymphoma, large b-cell, diffuse - mortality (11) 11
patients (11) 11
therapy (11) 11
diffuse large b-cell lymphoma (10) 10
kaplan-meier estimate (10) 10
lymphoma, follicular - drug therapy (10) 10
adolescent (9) 9
diagnosis (9) 9
outcomes (9) 9
phase-ii (9) 9
analysis (8) 8
chop (8) 8
chronic lymphocytic-leukemia (8) 8
cyclophosphamide (8) 8
disease (8) 8
elderly-patients (8) 8
epidemiology (8) 8
lymphoma, follicular - therapy (8) 8
lymphoma, large b-cell, diffuse - drug therapy (8) 8
proportional hazards models (8) 8
survival analysis (8) 8
transplantation (8) 8
1st-line treatment (7) 7
antibodies, monoclonal, murine-derived - administration & dosage (7) 7
antineoplastic agents - therapeutic use (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
follow-up studies (7) 7
health aspects (7) 7
hematology, oncology and palliative medicine (7) 7
immunotherapy (7) 7
lymphoma, follicular - pathology (7) 7
lymphoma, non-hodgkin - drug therapy (7) 7
patient outcomes (7) 7
prednisone (7) 7
radiation (7) 7
radiation therapy (7) 7
research (7) 7
risk factors (7) 7
seer program (7) 7
survival rate (7) 7
anthracyclines (6) 6
cyclophosphamide - administration & dosage (6) 6
doxorubicin - administration & dosage (6) 6
immune system diseases (6) 6
mantle cell lymphoma (6) 6
multicenter (6) 6
non-hodgkin's lymphomas (6) 6
non‐hodgkin lymphoma (6) 6
radiology, nuclear medicine & medical imaging (6) 6
risk (6) 6
toxicity (6) 6
trial (6) 6
vincristine (6) 6
chemoimmunotherapy (5) 5
classification (5) 5
cohort studies (5) 5
incidence (5) 5
indolent lymphoma (5) 5
lymphoma, large b-cell, diffuse - diagnosis (5) 5
lymphoma, mantle-cell - pathology (5) 5
lymphoma, non-hodgkin - pathology (5) 5
medicine & public health (5) 5
molecular targeted therapy (5) 5
plus rituximab (5) 5
prednisone - administration & dosage (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 10/2018, Volume 132, Issue 14, pp. 1465 - 1467
In this issue of Blood, Morschhauser et al report the safety and efficacy of lenalidomide in combination with obinutuzumab and establish the recommended phase... 
HEMATOLOGY | RITUXIMAB | INHIBITION
Journal Article
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 08/2018, Volume 32, Issue 8, pp. 404 - 407
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 11/2018, Volume 2018, Issue 1, pp. 189 - 193
Journal Article
Cancer, ISSN 0008-543X, 10/2015, Volume 121, Issue 19, pp. 3387 - 3389
Journal Article
Current Treatment Options in Oncology, ISSN 1527-2729, 7/2018, Volume 19, Issue 7, pp. 1 - 16
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e19559 - e19559
Journal Article
Current treatment options in oncology, 05/2018, Volume 19, Issue 7, p. 32
Even in the modern era, follicular lymphoma (FL) remains largely an incurable but treatable disease with both standard and novel treatment modalities. Despite... 
Retreatment | Lymphoma, Follicular - therapy | Animals | Prognosis | Clinical Decision-Making | Humans | Lymphoma, Follicular - diagnosis | Treatment Outcome | Combined Modality Therapy - methods | Disease Management | Combined Modality Therapy - adverse effects | Lymphoma, Follicular - etiology
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 2922 - 2922
Abstract Background DLBCL is the most commonly occurring form of non-Hodgkin lymphoma and is a highly curable disease, but one that is universally fatal if... 
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 04/2013, Volume 119, Issue 8, pp. 1570 - 1577
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 2, pp. 160 - 168
Journal Article
Blood, ISSN 0006-4971, 06/2014, Volume 123, Issue 23, pp. 3530 - 3531
In this issue of Blood , Tao et al provide a retrospective analysis of a large population-based data set to examine the relationships between socioeconomic... 
HEMATOLOGY | B-CELL LYMPHOMA | OUTCOMES | Lymphoma, Large B-Cell, Diffuse - mortality | Female | Male | Lymphoma, Large B-Cell, Diffuse - therapy | Health Status Disparities | Humans | Inside
Journal Article
Current oncology reports, 07/2015, Volume 17, Issue 7, p. 30
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1799 - 1799
Abstract Introduction While surveillance imaging does not appear to improve outcomes for patients with curable, aggressive non-Hodgkin lymphoma (NHL) achieving... 
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. TPS3109 - TPS3109
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.